- Home
- SVRA vs CLW Comparison
SVRA vs CLW Comparison
Compare SVRA & CLW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SVRA
- CLW
- Stock Information
- Founded
- SVRA N/A
- CLW 2005
- Country
- SVRA United States
- CLW United States
- Employees
- SVRA N/A
- CLW N/A
- Industry
- SVRA Biotechnology: Pharmaceutical Preparations
- CLW Paper
- Sector
- SVRA Health Care
- CLW Basic Materials
- Exchange
- SVRA Nasdaq
- CLW Nasdaq
- Market Cap
- SVRA 540.6M
- CLW 501.0M
- IPO Year
- SVRA N/A
- CLW N/A
- Fundamental
- Price
- SVRA $2.80
- CLW $31.02
- Analyst Decision
- SVRA Buy
- CLW Buy
- Analyst Count
- SVRA 7
- CLW 1
- Target Price
- SVRA $9.86
- CLW $37.00
- AVG Volume (30 Days)
- SVRA 966.0K
- CLW 534.1K
- Earning Date
- SVRA 03-06-2025
- CLW 02-18-2025
- Dividend Yield
- SVRA N/A
- CLW N/A
- EPS Growth
- SVRA N/A
- CLW N/A
- EPS
- SVRA N/A
- CLW 0.88
- Revenue
- SVRA N/A
- CLW $2,211,900,000.00
- Revenue This Year
- SVRA N/A
- CLW N/A
- Revenue Next Year
- SVRA N/A
- CLW N/A
- P/E Ratio
- SVRA N/A
- CLW $257.11
- Revenue Growth
- SVRA N/A
- CLW 58.65
- 52 Week Low
- SVRA $2.60
- CLW $23.97
- 52 Week High
- SVRA $5.70
- CLW $57.13
- Technical
- Relative Strength Index (RSI)
- SVRA 39.71
- CLW 62.69
- Support Level
- SVRA $2.60
- CLW $28.11
- Resistance Level
- SVRA $3.14
- CLW $30.71
- Average True Range (ATR)
- SVRA 0.17
- CLW 1.22
- MACD
- SVRA -0.01
- CLW 0.06
- Stochastic Oscillator
- SVRA 32.79
- CLW 89.80
About SVRA Savara Inc.
Savara Inc is a biopharmaceutical company. It is focused on rare respiratory diseases. The company's program, molgramostim nebulizer solution (molgramostim), is an inhaled granulocyte-macrophage colony-stimulating factor in Phase 3 development for autoimmune pulmonary alveolar proteinosis (aPAP). It has one segment specialty pharmaceuticals within the respiratory system.
About CLW Clearwater Paper Corporation
Clearwater Paper Corp is engaged in the manufacturing and selling of private label tissue, paperboard, and pulp-based products. The company has two reportable segments namely the consumer products segment which manufactures and sells a complete line of at-home tissue products as well as AFH products. The pulp and paperboard segment manufactures and markets bleached paperboard for the high-end segment of the packaging industry as well as offers services that include custom sheeting, slitting and cutting of paperboard. It generates maximum revenue from Pulp and Paperboard segment. Geographically, it derives maximum revenue from the United States.